GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: Forvisirvat is the INN for a sirtuin activator (WHO INN proposed list 133, July 2025). It is one of the compounds claimed in Sirtsei Pharmaceuticals' patent WO2021202822A1 [2]. The structure was disclosed as the sirtuin 6 activator clinical candidate SP-624 in early 2025, with suggested potential in psychiatric, neurodegenerative and metabolic disorders [3].
|
|
Bioactivity Comments |
SP-624 activates SIRT6 deacetylation of histone peptides and of nucleosomal H3K9 and H3K18. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|